Previous 10 | Next 10 |
home / stock / cphrf / cphrf news
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results Canada NewsWire Adjusted EBITDA increases 9% to $13.7 million and EPS increases 60% to $0.16 ( CDN$0.21 1 ) for the full year OAKVILLE, ...
Cipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call Canada NewsWire OAKVILLE, ON , March 10, 2021 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or "the Company ") today announced it will release its Q4 2...
Cipher Pharmaceuticals Receives Arbitration Award on Trulance® Canada NewsWire OAKVILLE, ON , Jan. 15, 2021 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced it has received an arbitration award in the previously...
Cipher Pharmaceuticals, Inc. (CPHRF) Q3 2020 Earnings Conference Call November 13, 2020 8:30 AM ET Company Participants Craig Mull – Interim Chief Executive Officer Scott Langille – Chief Financial Officer Conference Call Participants Prasath Pandurangan – Bloom Burton Do...
Cipher Pharmaceuticals (CPHRF): Q3 GAAP EPS of $0.06 beats by $0.02.Revenue of $4.9M (-15.5% Y/Y) beats by $0.94M.Press Release For further details see: Cipher Pharmaceuticals EPS beats by $0.02, beats on revenue
Cipher Pharmaceuticals Reports Third Quarter 2020 Financial Results Canada NewsWire OAKVILLE, ON, Nov. 12, 2020 Revenue Increases Sequentially to $4.9 million EBITDA 2 was $2.7 million or 55% of net revenue OAKVILLE, ON , Nov. 12, 2020...
Cipher Pharmaceuticals Schedules Q3 2020 Earnings Release and Conference Call Canada NewsWire OAKVILLE, ON, Nov. 3, 2020 OAKVILLE, ON, Nov. 3, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or "the Company ") today announced it ...
Cipher Pharmaceuticals Reports Voting Results for the Election of Directors Canada NewsWire OAKVILLE, ON, Oct. 8, 2020 Announces Appointment Of Cathy Steiner To Board Of Directors OAKVILLE, ON , Oct. 8, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TS...
Cipher Pharmaceuticals Inc. (CPHRF) Q2 2020 Earnings Conference Call August 13, 2020 8:30 am ET Company Participants Craig Mull - Chief Executive Officer Scott Langille - Chief Financial Officer Conference Call Participants Doug Loe - Echelon Partners André Uddin - Mac...
Cipher Pharmaceuticals Announces Normal Course Issuer Bid Canada NewsWire OAKVILLE, ON, Aug. 12, 2020 OAKVILLE, ON , Aug. 12, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or the " Company ") announced today that it has filed, and the Toronto Stock Excha...
News, Short Squeeze, Breakout and More Instantly...
Companhia Siderurgica Paulista Nova Cosipa Company Name:
CPHRF Stock Symbol:
OTCMKTS Market:
Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders Canada NewsWire MISSISSAUGA, ON , June 14, 2024 /CNW/ - Cipher Pharmaceuticals Inc . (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the "Company ") today announced that i...
Cipher Pharmaceuticals Reports First Quarter 2024 Results Canada NewsWire (All figures are presented in U.S. Dollars) Adjusted EBITDA in Q1 2024 was $3.6 million , an increase of 12.5% over Q1 2023 Epuris sales volumes grew 7.2% in the quarter over Q1 2023, c...
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , May 3, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release ...